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1. Introduction
  The concept of developing drugs from plants in indigenous 
medical system is much older, while in some cases direct 
links between a local and biomedical use exists, in other 
cases the relationship is much more complex[1]. Hyptis is 
a genus of Lamiaceae with about 400 species. One of the 
species from genus, Hyptis suaveolens Poit (referred as 
Hyptis hereafter) is naturalized in India[2]. Its distribution is 
tropical and subtropical and it is not commonly found over 
500 m. A plenty of traditional herbal medicinal practices 
have been used in the diagnosis, prevention and treatment 
of diabetes. The plant, Hyptis suaveolens (L) Poit commonly 
known as Wilayati tulsi is an ethnobotanically important 
medicinal plant. The plant has been considered as an 
obnoxious weed, distributed throughout the tropics and 
subtropics. Almost all parts of this plant are being used 
in traditional medicine to treat various diseases. Leaves 
of Hyptis suaveolens have been utilized as a stimulant, 
carminative, sudorific, galactogogue and as a cure for 
parasitic cutaneous diseases[3]. Crude leaf extract is also 
used as a relief to colic and stomachache. Leaves and 
twigs are considered to be antispasmodic and used in 
antirheumatic and antisuporific baths, antiinflammatory, 
antifertility agents[4] and also applied as an antiseptic in 
burns, wounds, and various skin complaints. The decoction 
of roots is highly valued as appetizer and is reported to 
contain urosolic acid, a natural HIV-integrase inhibitor[5]. 
Though there is no scientific evidence to support the 
antidiabetic effect of Hyptis suaveolens, tribal men continue 
to use the plant in the treatment of diabetes. The objective 
of this investigation was to ascertain the scientific basis 
for the use of this plant in the treatment of diabetes using 
streptozotocin model. 
2. Materials and methods
2.1. Plant extract preparation 
  Dried leaves of Hyptis suaveolens (Lamiaceae) were 
procured from in and around Shevaroy hills, Yercaud in the 
month of April 2009 and were identified and authenticated 
by taxonomist of the Botanical Survey of India, Yercaud, 
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Tamilnadu, India. The coarsely powdered material was 
exhaustively extracted thrice with 50% aqueous ethanol, and 
the yield of Hyptis suaveolens extract (HSE) was 9.5% (w/w)
2.2. Animals
  Sprague-Dawley rats (150-200 g) and Swiss albino mice 
(20-25 g) of either sex and of approximately the same 
age were procured from the animal house of the Central 
Drug Research Institute, Lucknow. They were kept in 
the departmental animal house at (26依2)℃ and relative 
humidity 44%-56% in polypropylene cages. Animals were 
exposed to alternate 12 hrs of darkness and light each. 
Animals were provided with standard rodent pellet diet 
(Dayal, India) and the food was withdrawn18-24 h before 
the experiment though water was allowed ad libitum. The 
experimental protocol has been approved by the Institutional 
Animal Ethics Committee and by the regulatory body of the 
government.
2.3. Chemicals
  Streptozotocin was purchased from Sigma Aldrich 
Chemicals Pvt, Ltd, Bangalore. All other chemicals and 
reagents used were of analytical grade.
2.4. Experimental induction of diabetes
  All animals were allowed to adapt to cages for 3 days, after 
which they were fasted overnight. Diabetes was induced 
in rats by intra peritoneal injection of streptozotocin at 
a dose of 50 mg/kg, dissolved in normal saline[6]. After 
streptozotocin treatment, all animals were given free access 
to food and water. Blood glucose levels were measured 2 
days after streptozotocin injection and used as parameters to 
match pairs of diabetic rats with similar level of severity. Only 
rats with fasting blood glucose levels higher than 200 mg/dL
were considered to be diabetic and were used in the 
experiment. The mean blood concentration of glucose in 
normoglycemic rats was 95 mg/dL. Animals were randomly 
assigned to four different groups ie. group Ⅱ to Ⅴ. Group 
Ⅰ served as normal control containing 6 normal rats. All 
treatments started 2 days after Streptozotocin injection. 
Vehicles and the drugs were administered orally using oral 
gavage tube daily for 3 weeks. Blood samples were collected 
for the measurement of blood glucose level from the tail 
vein on 0 day, 7th, 14th and 21st day. The blood glucose 
level was determined by glucometer (one touch). Values 
of sample treated were compared with that of the standard 
group which was treated with glibenclamide. Then animals 
were sacrificed by cervical dislocation. The liver, kidney 
and pancreas were exposed and perfused with cold saline 
phosphate buffer of pH 7.4 for histopathological examination. 
Blood free liver and kidney were taken out and homogenized 
in a glass Teflon homogenizer separately (10% w/v). 
Incubation was done at 37 ℃ under controlled conditions for 
biochemical estimation. The collected blood samples were 
immediately centrifuged at 2 500 rpm for 15 min. The serum 
separated was collected in fresh serum tubes and stored in 
refrigerator (2-4℃) after tightly capped[7]. 
2.5. Antioxidant assay
2.5.1. DPPH radical scavenging activity
  The free radical scavenging activity was measured in terms 
of hydrogen donating or radical scavenging ability, using 
the stable radical, DPPH[8]. A 0.1 mM solution of DPPH in 
methanol was prepared and 1 mL of this solution was added 
to 3 mL of control ie. standard butylated hydroxyl toluene 
(BHT) at different concentration (25-100 毺g/mL) and test 
solutions at different concentrations (5-100 毺g/mL) in 
different test tubes. Thirty minutes later, the absorbance 
were measured at 517 nm.
2.5.2. Nitric oxide scavenging activity 
  Nitric oxide scavenging activity was measured by the 
spectrophotometric method[9]. Sodium nitroprusside (5 mM)
in phosphate-buffer saline was mixed with a control without 
the test compound, but with an equivalent amount of 
methanol. Test solutions at different concentrations (5-100 
毺g/mL) were dissolved in methanol and incubated at 25 
℃ for 30 min. After 30 min, to 1.5 mL of the incubated 
solution was diluted with 1.5 mL of Griess reagent (1% 
sulphanilamide, 2% phosphoric acid and 0.1% naphthyl 
ethylenediamine dichloride). The absorbance of the 
chromophore formed during the diazotization of the nitrile 
with sulphanilamide and the subsequent coupling with 
naphthyethylene diamine dihydrochloride was measured at 
546 nm.
2.5.3. Superoxide scavenging activity
  Superoxide scavenging was carried out using the alkaline 
dimethyl sulfoxide (DMSO) method[9]. Solid potassium 
superoxide was allowed to stand in contact with dry DMSO 
for at least 24 h and the solution was filtered immediately 
before use. The filtrate (200 毺L) was added to 2.8 mL of an 
aquous solution containing nitroblue tetrazolium (56 毺M),
ethylenediaminetetraacetic acid (EDTA) (10 毺M) and 
potassium phosphate buffer (10 毺M, pH 7.4). Test solutions 
at different concentrations (5-100 毺g/mL) were added and 
absorbances were recorded at 560 nm against the control.
2.5.4. Hydroxyl radical scavenging activity
  The scavenging capacity for hydroxyl radical was 
determined according to the modified method[10]. The 
assay was performed by adding 0.1 mL of EDTA, 0.01 mL 
of ferric chloride, 0.1 mL of hydrogen peroxide, 0.36 mL 
of deoxyribose, 1.0 mL of test solutions (5-100 毺g/mL) in 
distilled water, 0.33 mL of phosphate buffer (50 mM, pH 
7.4) and 0.1 ml of ascorbic acid were dissolved in sequence. 
The mixture was then incubated at 37 ℃ for 1 hr and 1.0 mL 
portion of the incubated mixture was mixed with 10% TCA 
and 1.0 mL of 0.5% TBA to develop the pink chromogen and 
measured at 532 nm.
2.6. Statistical analysis
  Data were statistically calculated by utilizing one way 
ANOVA and expressed as mean依SEM followed by Donnett’s 
t-test using computerized graph pad in stat version 3.05 
graph pad software USA. Differences of P<0.05 were 
considered statistically significant.
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3. Results 
3.1. Anti-hyperglycemic activity of Hyptis suaveolens 
  The effect of 50% ethanolic extract of leaves of Hyptis 
suaveolens on streptozotocin-induced animals is shown 
in Table 1 and Table 2. Table 1 showed the effect of oral 
administration of 250 mg/kg/day and 500 mg/kg/day of 
HSE on blood glucose level. After 21 days, at the end of 
treatment, reduction in blood glucose level of treated rats 
with dose 250 mg/kg was 116.50-219.50 mg/dL (P< 0.01). 
After oral administration of 500 mg/kg of HSE, blood glucose 
level in 21 days was 98.83-237.00 mg/dL(P< 0.01). While in 
case of glibenclamide 600 毺g/kg, it was 94.50-232.33 mg/dL
(P< 0.01). Table 2 showed that the serum triglyceride (TG), 
total cholesterol, low density lipoprotein (LDL) and very 
low density lipoprotein (VLDL) levels were significantly 
higher in diabetic rats compared to those in normal and 
drug treated rats, while high density lipoprotein (HDL) levels 
were significantly decreased in the model rats compared to 
those in normal rats. After the treatment with 50% ethanolic 
extract of Hyptis suaveolens in the diabetic rats, a significant 
reduction in serum cholesterol, TG, LDL and VLDL were 
observed. In antioxidant assay, potential decrease in the 
concentration of DPPH radial due to scavenging property 
of methanolic extract of Hyptis suaveolens (MEHS) and 
BHT showed significant free radical scavenging activity 
viz. 86.44% and 91.86%, respectively at 100 毺g/mL.
The scavenging of nitric oxide by MEHS and BHT was 
concentration dependent. There was a moderate inhibition 
of nitric oxide formation with the maximum inhibition being 
74.12% and 82.14%, respectively at 100 毺g/mL MEHS and 
BHT. The MEHS and BHT showed a moderate inhibition of 
the superoxide radical 75.50% and 81.87%, respectively at 
100 毺g/mL. 
  The effect of MEHS and BHT on hydroxyl radical and 
iron (Ⅱ)-dependent deoxyribose damage was protected 
significantly at all concentrations. The percentage of 
inhibition of hydroxyl radical being 68.84% and 73.56% 
respectively at 100 毺g/mL(Table 3).
3.2. Histopathological studies
3.2.1. Pancreas
  Microscopically examined pancreas section of control 
group (1A) showed normal architecture with acini of serous 
epithelial cells along with nest of endocrine cells separated 
by fibrocollagenous stroma into lobules. No fibrosis or any 
inflammation was seen.
  Microscopically examined pancreas section of diabetic 
control group (1B) showed architecture with acini of serous 
epithelial cells along with nest of endocrine cells separated 
by fibrocollagenous stroma into lobules. Focal lymphocytic 
infiltrate was present in stroma.
  Microscopically examined pancreas section of 50% 
ethanolic extract of leaves of Hyptis suaveolens treated group 
(1C and 1D) showed normal architecture with acini of serous 
epithelial cells along with nest of endocrine cells separated 
by fibrocollagenous stroma into lobules. No fibrosis or any 
inflammation was seen. 
  The normal architecture was restored to the same as that of 
the standard drug (Glibenclamide) treated pancreas (1E). 
           A                                                      B
               C                                                  D
        E       
Figure 1. Histopathology of pancreas.
A: Control group; B: Diabetic control group; C: 50% ethanolic extract of 
leaves of Hyptis suaveolens treated group at 250 mg/kg; D: 50% ethanolic 
extract of leaves of Hyptis suaveolens treated group at 500 mg/kg;
E: Glibenclamide treated group.
3.2.2. Kidney
  Microscopically examined kidney section of control group 
(2A) showed the glomerulli appear normal. The tubules 
stroma appeared normal.  
  Microscopically examined kidney section of diabetic 
control group (2B) showed the moderate increase in 
mesengial cellularity and matrix. Tubules appeared normal 
and lined by single layer of cuboidal cells. The stroma 
revealed focal lymphoplasmacytic infiltrates.
  Microscopically examined kidney section of 50% ethanolic 
extract of leaves of Hyptis suaveolens treated group (2C) showed 
the moderate increase in mesengial cellularity and matrix. 
Tubules appeared normal. The stroma showed mild infiltration 
by lymphocytes, plasma cells and glomeruli and mild increase 
in mesengial cellularity. The tubules appeared normal. The 
stroma was infiltrated by lymphoplasmacytic cells (2D).
  The normal architecture was restored to the same as that of 
the standard drug (Glibenclamide) treated kidney (2E). 
3.2.3. Liver
  Microscopically examined liver section of control group 
(3A) showed normal architecture with central veins, 
sinusoids and portal triads appeared normal. Hepatocytes 
showed moderate cytoplasm and round to oval nuclei.
  Microscopically examined liver section of diabetic control 
group (3B) showed architecture was distorted. The central 
veins showed congestion. Hepatocytes showed feathery 
degeneration. Portal triads showed peri-portal inflammation 
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composed of lymphocytes.
          A                                                      B
             C                                                   D
         E       
Figure 2. Histopathology of kidney.
A: Control group; B: Diabetic control group; C: 50% ethanolic extract 
of leaves of Hyptis suaveolens treated group at 250 mg/kg; D: 50% 
ethanolic extract of leaves of Hyptis suaveolens treated group at 500 
mg/kg; E: Glibenclamide treated group.
  Microscopically examined liver section of 50% ethanolic 
extract of leaves of Hyptis suaveolens treated group (3C) 
showed the architecture was partially effaced. There was 
chronic venous congestion and patchy necrosis. The portal 
triads showed hepatocytes had feathery degeneration and 
mild chronic inflammation composed of lymphocytes. Portal 
triads were normal. Hepatocytes appeared normal and 
showed moderate cytoplasm and round to oval nuclei. There 
was no feathery degeneration of the hepatocytes (3D).
 
              A                                                     B
               C                                                       D
         E        
Figure 3. Histopathology of liver.
A: Control group; B: Diabetic control group; C: 50% ethanolic extract 
of leaves of Hyptis suaveolens treated group at 250 mg/kg; D: 50% 
ethanolic extract of leaves of Hyptis suaveolens treated group at 500 
mg/kg; E: Glibenclamide treated group.
Table 1
Effects of 50% ethanolic extract of leaves of Hyptis suaveolens on blood glucose levels in streptozotocin induced diabetic rats(Mean 依 SEM)(mg/
dL).
Treatment 0 day 7 days 14 days 21 days 
Normal control 76.16依5.36 75.66 依 3.94 75.00依4.96 75.00依4.61
Diabetic control 220.83依19.00    214.50依 10.60**     211.33依20.30**      208.16依17.38 **
HSE(250 mg/kg) 219.50依13.25 191.00依15.35 164.50依19.45        116.83依19.16 △△
HSE( 500 mg/kg) 237.00依15.00 190.16依16.14      132.66依11.01 △          98.83依10.55 △△
Glibenclamide(600 毺g/kg) 232.33依13.90 184.83依12.80     129.83依19.20
△        94.50依5.46 △△
** P<0.01 vs. normal control; △P<0.05,△△P<0.01 vs. diabetic control.
Table 2
Effects of 50% ethanolic extract of leaves of Hyptis suaveolens on the total cholesterol and triglyceride level in blood serum after 21 days(Mean 依 
SEM)(mg/dL).
Treatment TG   Total cholesterol HDL LDL VLDL
Normal control    67.25 依 4.54 74.36 依 5.46 23.80 依 2.10 35.30 依 3.30 13.30 依 1.70
Diabetic control  112.62 依 6.36 152.86 依 7.54**   13.30 依 3.10**   71.70 依 8.30**   30.30 依 1.10**
HSE (250 mg/kg)   71.54 依 5.25   78.36 依 5.38△      18.20 依 0.90△△   47.20 依 6.70△   20.70 依 2.10△
HSE (500 mg/kg)   68.32 依 4.37     72.52 依 6.56△△      18.90 依 0.90△△   45.20 依 5.30△   19.00 依 2.00△
Glibenclamide(600 毺g/kg)   82.46 依 4.23     89.52 依 6.46
△△      19.20 依 1.00△△    40.20 依4.50△△      17.80 依 2.00△△
** P<0.01 vs. normal control; △P<0.05,△△P<0.01 vs. diabetic control.
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 The normal architecture was restored to the same as that 
of the standard drug (Glibenclamide) treated liver (3E). It 
was evident that 50% ethanolic extract of leaves of Hyptis 
suaveolens possessed good antidiabetic activity.
4. Discussion
  Streptozotocin as an antibiotic and anticancer agent 
has been widely used for inducing type Ⅰ diabetes in a 
variety of animals by affecting degeneration and necrosis 
of pancreatic 毬-cells[11]. It has been demonstrated that 
insulin deficiency in diabetes mellitus leads to a variety of 
derangements in metabolic and regulatory process, which 
in turns leads to accumulation of lipids such as cholesterol 
and triglyceride in diabetic patients. The abnormal high 
concentration of serum lipids in the diabetic subject is 
mainly due to increase in the mobilization of free fatty 
acids from the peripheral fat depots. In oxidative stress, 
where large quantities of reactive oxygen species (ROS) like 
hydrogen peroxide, superoxide, hydrogen radical, singlet 
oxygen and nitrogen species are generated, one of the 
earliest responses to stress. These ROS have a role in disease 
and aging in animals. The antioxidative system protects the 
organism against ROS-induced oxidative damage. There 
are restrictions on the use of synthetic antioxidants such 
as BHT, as they are suspected to be carcinogenic. Natural 
antioxidants therefore have gained importance[12]. DPPH is 
a stable free radical and accepts an electron or hydrogen 
radical to become a stable diamagnetic molecule. The 
reduction capability of DPPH radical is determined by the 
decrease in absorbance at 517 nm induced by antioxidants[13]. 
The significant decrease in the concentration of DPPH 
radical is due to the scavenging ability of MEHS. Nitric oxide 
is a potent pleiotropic mediator of physiological processes 
such as smooth muscle relaxation, neuronal signaling, 
inhibition of platelet aggregation and regulation of cell 
mediated toxicity. MEHS was shown significant scavenging 
activity. Hydroxyl radicals are the major active oxygen 
species that cause lipid oxidation and enormous biological 
damage[14]. The MEHS has potent antioxidant and free 
radical scavenging effects in different in-vitro systems. The 
present studies demonstrated that the 50% ethanolic extract 
of Hyptis suaveolens had an antihyperglycemic effect in the 
streptozotocin induced diabetic rats when administered 
orally along with antioxidant as well as decrease the 
cholesterol and triglyceride levels in the significant manner. 
The current study provides some useful insight into the 
antihyperglycemic potency of Hyptis suaveolens leaves in 
streptozotocin induced diabetes. However, we suggest that 
further work should be carried out at molecular level to 
find out the absolute mechanism of action of plant Hyptis 
suaveolens in experimental diabetes.
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